Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1976 Jul;25(1):17–22.

T, B and K cells in autoimmune thyroid disease.

E A Calder, W J Irvine, N M Davidson, F Wu
PMCID: PMC1541376  PMID: 1086749

Abstract

The K-cell cytotoxic activity of peripheral blood lymphoid cells from 104 patients with autoimmune thyroid disease and from age and sex matched control subjects was measured using chicken erythrocytes as target cells. Patients with Hashimoto thyroiditis,primary hypothyroidism and thyrotoxicosis who were either newly diagnosed and untreated or had received therapy for less than or equal to 1 year showed a significant increase in K-cell cytotoxic activity. Patients who had received treatment for greater than 1 year and less than or equal to 5 years showed no such comparable increase in cytotoxic activity. Within the group of patients with untreated thyrotoxicosis it was found that K-cell cytotoxic activity was related to both goitre size and serum antibody titre. Thus patients with little or no goitre showed a highly significant elevation of cytotoxic activity whereas patients with moderate to large goitres gave values within the normal range. Similarly patients with no detectable serum thyroid autoantibodies showed high K-cell activity while patients with positive antibody titres did not. It was also shown that neither the absolute number nor the proportion of circulating T and B lymphocytes in patients with autoimmune thyroid disease as assessed by the sheep red cell rosette method and by indirect immunofluorescence was significantly different from that observed in the normal control population. No correlation was found between peripheral blood K-cell cytotoxic activity and the percentage of circulating null cells, i.e. 100-(percentage T + percentage B) in either patients or control subjects.

Full text

PDF
17

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calder B. A., Penhale W. J., Barnes E. W., Irvine W. J. Cytotoxic lymphocytes in Hashimoto thyroiditis. An in vitro assay system using 51 Cr-labelled chicken red blood cells coated with thyroglobulin. Clin Exp Immunol. 1973 May;14(1):19–23. [PMC free article] [PubMed] [Google Scholar]
  2. Calder E. A., Penhale W. J., McLeman D., Barnes E. W., Irvine W. J. Lymphocyte-dependent antibody-mediated cytotoxicity in Hashimoto thyroiditis. Clin Exp Immunol. 1973 Jun;14(2):153–158. [PMC free article] [PubMed] [Google Scholar]
  3. Calder E. A., Urbaniak S. J., Penhale W. J., Irvine W. J. Characterization of human lymphoid cell-mediated antibody-dependent cytotoxicity (LDAC). Clin Exp Immunol. 1974 Dec;18(4):579–593. [PMC free article] [PubMed] [Google Scholar]
  4. Farid N. R., Munro R. E., Row V. V., Volpé R. Peripheral thymus-dependent (T) lymphocytes in Graves's disease and Hashimoto's thyroiditis. N Engl J Med. 1973 Jun 21;288(25):1313–1317. doi: 10.1056/NEJM197306212882502. [DOI] [PubMed] [Google Scholar]
  5. Lamon E. W., Skurzak H. M., Klein E., Wigzell H. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen. J Exp Med. 1972 Nov 1;136(5):1072–1079. doi: 10.1084/jem.136.5.1072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MacLennan I. C. Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev. 1972;13:67–90. doi: 10.1111/j.1600-065x.1972.tb00060.x. [DOI] [PubMed] [Google Scholar]
  7. Perlmann P., Perlmann H., Müller-Eberhard H. J. Lymphocyte-mediated cytotoxicity induced by humoral antibodies. Mechanism of induction and surface markers of the effector cells. Int Arch Allergy Appl Immunol. 1973;45(1):278–280. doi: 10.1159/000231041. [DOI] [PubMed] [Google Scholar]
  8. Pollack S., Heppner G., Brawn R. J., Nelson K. Specific killing of tumor cells in vitro in the presence of normal lymphoid cells and sera from hosts immune to the tumor antigens. Int J Cancer. 1972 Mar 15;9(2):316–323. doi: 10.1002/ijc.2910090209. [DOI] [PubMed] [Google Scholar]
  9. Urbaniak S. J., Penhale W. J., Irvine W. J. Circulating lymphocyte subpopulations in Hashimoto thyroiditis. Clin Exp Immunol. 1973 Nov;15(3):345–354. [PMC free article] [PubMed] [Google Scholar]
  10. Urbaniak S. J., Penhale W. J., Irvine W. J. Peripheral blood T and B lymphocytes in patients with thyrotoxicosis and Hashimoto's thyroiditis and in normal subjects. A comparison of lymphocyte separation methods. Clin Exp Immunol. 1974 Dec;18(4):449–459. [PMC free article] [PubMed] [Google Scholar]
  11. Volpé R., Row V. V. Letter: Proportion of E rosettes normal in Graves's and Hashimoto's disease: a retraction. N Engl J Med. 1975 Jul 3;293(1):44–44. doi: 10.1056/NEJM197507032930115. [DOI] [PubMed] [Google Scholar]
  12. Wara D. W., Reiter E. O., Ammann A. J., Kaplan S. L. Letter: T-cell rosettes in thyrotoxic Grave's disease. N Engl J Med. 1973 Nov 22;289(21):1145–1146. doi: 10.1056/NEJM197311222892115. [DOI] [PubMed] [Google Scholar]
  13. Wasserman J., von Stedingk L. V., Perlmann P., Jonsson J. Antibody-induced in vitro lymphocyte cytotoxicity in Hashimoto thyroiditis. Int Arch Allergy Appl Immunol. 1974;47(4):473–482. doi: 10.1159/000231241. [DOI] [PubMed] [Google Scholar]
  14. Wisloff F., Michaelsen T. E., Froland S. S. Inhibition of antibody-dependent human lymphocyte-mediated cytotoxicity by immunoglobulin classes, IgG subclasses, and IgG fragments. Scand J Immunol. 1974;3(1):29–38. doi: 10.1111/j.1365-3083.1974.tb01230.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES